NAD+ is an essential cellular coenzyme involved in redox chemistry and energy metabolism. As a substrate for sirtuins, PARPs and CD38, it is researched in mitochondrial regulation, DNA-damage signalling, stress responses and metabolic communication.
Current work examines NAD+ availability and NAD-dependent pathways as mechanistic and translational research questions, not established clinical benefits.
Explore NAD+ researchResearch context only; not a therapeutic claim.GHK-Cu is a copper-binding tripeptide studied in gene-expression, extracellular-matrix, collagen- and elastin-related pathways, cellular migration, copper homeostasis and oxidative-stress responses.
Research also examines skin and tissue-repair mechanisms. Evidence remains primarily laboratory, preclinical or cosmetic and does not establish a therapeutic benefit.
Explore GHK-Cu researchResearch context only; not a therapeutic claim.Revitalise Research Ltd, trading as Revitalise Peptides.
Company number: 17260326
Registered in England and Wales.
Registered office: 128 City Road, London, United Kingdom, EC1V 2NX.
Email: support@revitalise-peptides.com
For order enquiries, include your order number. For batch documentation or compliance questions, identify the product and batch where available.